Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Gimatecan exerts potent antitumor activity against gastric cancer in vitro and in vivo via AKT and MAPK signaling pathways ; volume:15 ; number:1 ; day:13 ; month:12 ; year:2017 ; pages:1-11 ; date:12.2017
Journal of translational medicine ; 15, Heft 1 (13.12.2017), 1-11, 12.2017
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Chen, Zuhua
- Beteiligte Personen und Organisationen
-
Liu, Zhentao
Huang, Wenwen
Li, Zhongwu
Zou, Jianling
Wang, Jingyuan
Lin, Xiaoting
Li, Beifang
Chen, Dongshao
Hu, Yanting
Ji, Jiafu
Gao, Jing
Shen, Lin
SpringerLink (Online service)
- DOI
-
10.1186/s12967-017-1360-z
- URN
-
urn:nbn:de:1111-201802111592
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Zuhua
- Liu, Zhentao
- Huang, Wenwen
- Li, Zhongwu
- Zou, Jianling
- Wang, Jingyuan
- Lin, Xiaoting
- Li, Beifang
- Chen, Dongshao
- Hu, Yanting
- Ji, Jiafu
- Gao, Jing
- Shen, Lin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer
CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest
Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis
Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint
Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer
A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer
Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study
A new localization set for generalized eigenvalues
Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer
CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest
Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis
Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint
Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer
A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer
Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study
A new localization set for generalized eigenvalues
Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel
Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer
CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest
Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis
Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint
Liquid biopsy: a powerful tool to monitor trastuzumab resistance in HER2-positive metastatic gastric cancer
Targeting autophagy potentiates antitumor activity of Met-TKIs against Met-amplified gastric cancer
A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo
Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma
A prospective study on the changes and clinical significance of pre-operative and post-operative circulating tumor cells in resectable gastric cancer
Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study